Why EGFR Drugs Fail in Glioblastoma: A STAT3 Escape Route Takes Center Stage
A new review argues that glioblastoma evades EGFR-targeted therapies through compensatory STAT3 activation, positioning the EGFR–STAT3 axis as an adaptive ...
A new review argues that glioblastoma evades EGFR-targeted therapies through compensatory STAT3 activation, positioning the EGFR–STAT3 axis as an adaptive ...
Editors have retracted a 2019 study claiming that acteoside suppresses inflammation in osteoarthritic rats after duplicated images surfaced across unrelated ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine